Feasibility of Omega-3 Supplementation for Children With Language Impairments

Language Impairment Clinical Trial

Official title: Feasibility of Omega-3 Fatty Acid Supplementation for Children With Early Developmental Impairment in Language

Status Terminated

Clinical Trial Summary

The primary objective of this study is to obtain preliminary (pilot) data regarding the feasibility of using dietary omega-3 supplementation in children with significant delays in language skills; a related secondary objective is to compare adherence to a dosage schedule of two easy-to-take formulations. A tertiary objective of this study is to collect preliminary (pilot) data pre- and post-supplementation to identify potential improvement of skills in a specific area of language development.

Clinical Trial Description

HYPOTHESIS Hypothesis 1: Children with early developmental impairment in language will successfully take daily omega-3 fatty acid supplementation for a well-defined period of time (3 months); Hypothesis 2: Children with early developmental impairment will better adhere to administration of a small quantity of slightly fishy-tasting oil than to a large quantity of sweet-tasting paste; Hypothesis 3: A 3 month period of daily omega-3 supplementation will produce some improvement in fast-mapping language skills (a dynamic vocabulary learning skill that has been shown to rapidly improve after exposure to beneficial intervention). ;

Related Conditions & MeSH terms

• Language Disorders
• Language Impairment

• NCT number: NCT01640106
• Study type: Interventional
• Source: McGill University Health Centre/Research Institute of the McGill University Health Centre
• Status: Terminated
• Phase: N/A
• Start date: June 2012
• Completion date: June 2015